ANTH

Healthcare Biotechnology

Anthera Pharmaceuticals, Inc.

$0.00

+0.00 +0.00% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 11:00 AM ET	0.00

Key Stats

Market Cap

2,617.93

Avg Volume

348

52W High

$0.00

Div. Yield

0.0%

Valuation

Forward P/E

-0.00

P/B Ratio

0.00

EV/EBITDA

0.22

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(568.8%)

Return on Assets

(142.0%)

Liquidity & Leverage

Current Ratio

3.30

Quick Ratio

3.06

Total Cash

8.09M

Total Debt

About

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.